Evogene Ltd.
EVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,054 | -$25,954 | -$29,844 | -$30,445 |
| Dep. & Amort. | $2,504 | $2,612 | $2,580 | $2,234 |
| Deferred Tax | $9 | -$33 | $90 | $13 |
| Stock-Based Comp. | $1,795 | $1,877 | $1,186 | $2,609 |
| Change in WC | -$3,313 | -$400 | -$771 | $1,656 |
| Other Non-Cash | -$2,641 | $321 | $3,081 | -$906 |
| Operating Cash Flow | -$19,700 | -$21,577 | -$23,678 | -$24,839 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$626 | -$785 | -$1,171 | -$724 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,150 | -$10,703 | -$911 | -$24,114 |
| Inv. Sales/Matur. | $27,340 | $6,924 | $15,356 | $4,395 |
| Other Inv. Act. | $58 | $26 | $0 | $0 |
| Investing Cash Flow | $9,622 | -$4,538 | $13,274 | -$20,443 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$901 | -$836 | $9,197 | -$580 |
| Stock Issued | $123 | $8,449 | $21 | $29,582 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,434 | $10,539 | $125 | $1,274 |
| Financing Cash Flow | $4,656 | $18,152 | $9,343 | $30,276 |
| Forex Effect | -$49 | -$245 | -$2,284 | $1,102 |
| Net Chg. in Cash | -$5,471 | -$8,208 | -$3,345 | -$13,904 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,772 | $28,980 | $32,325 | $46,229 |
| End Cash | $15,301 | $20,772 | $28,980 | $32,325 |
| Free Cash Flow | -$20,326 | -$22,362 | -$24,849 | -$25,563 |